Name | (6S)-dehydrovomifoliol |
---|---|
Synonyms |
(4S)-4-Hydroxy-3,5,5-trimethyl-4-[(1E)-3-oxo-1-buten-1-yl]-2-cyclohexen-1-one
(6S)-dehydrovomifoliol 2-Cyclohexen-1-one, 4-hydroxy-3,5,5-trimethyl-4-[(1E)-3-oxo-1-buten-1-yl]-, (4S)- Dehydrovomifoliol |
Description | Dehydrovomifoliol is a AKT/mTOR dual inhibitor. Dehydrovomifoliol reduces lipid accumulation and lipogenesis by inhibiting the AKT/mTOR signaling pathway. Dehydrovomifoliol is used in nonalcoholic fatty liver disease research (NAFLD) . |
---|---|
Related Catalog | |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 367.4±42.0 °C at 760 mmHg |
Molecular Formula | C13H18O3 |
Molecular Weight | 222.28 |
Flash Point | 190.2±24.4 °C |
Exact Mass | 222.125595 |
LogP | 0.73 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.554 |
Storage condition | 2-8℃ |